From whole genomes to targeted panels, our Bioinformatics Analysis as a Service (BIAAS) transforms raw sequencing data into clinically and biologically meaningful insights. Whether it’s NGS, multi-omics, or clinical reporting, we deliver scalable, reproducible analyses, adapt pipelines to your data backed by deep expertise - so you get answers, not just outputs.
Detect mutations, CNVs, and structural variants in tumor samples. Differentiate driver vs passenger mutations. Support tumor-only and tumor–normal matched workflows.
Identify inherited mutations linked to rare diseases, Mendelian disorders, and familial syndromes. Includes SNPs, indels, CNVs. Prioritization via clinical databases (ClinVar, OMIM, HGMD).
Interpret variants affecting drug metabolism, efficacy, and toxicity. Generate actionable recommendations for personalized treatment.
Subclonal mutation detection to track tumor progression, relapse, or resistance. Support for liquid biopsy (ctDNA) and longitudinal monitoring.
Pathogen genome sequencing for outbreak tracking, resistance profiling. Metagenomic sequencing to detect unknown or mixed infections.
Integrating genomic with transcriptomic or epigenomic data for deeper insights in cancer and rare diseases.
Experience the future of bioinformatics with TWINE - Our no-code, AI-driven analysis suite.